本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Achieve Life Sciences, Inc.

2.36
-0.0400-1.67%
盤後2.360.00000.00%17:16 EDT
成交量:26.20萬
成交額:63.42萬
市值:8,185.68萬
市盈率:-1.90
高:2.48
開:2.39
低:2.36
收:2.40
資料載入中...
2021/05/27

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/05/25

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/30

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/30

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/30

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/13

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report